TherapeuticsMD

TherapeuticsMD

Pharmaceuticals
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

$25M

Market Cap • 9/14/2026

1907

(119 years)

Founded

2002

(24 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0,9

P/S

7,6

P/EBITDA

P/OCF

8,1

P/FCF

8,1

P/E

BVPS

2,3

EPS

Market Cap

Market Cap

25M

EV

20,3M

EV/Revenue

6,2

EV/EBITDA

-4,1

EV/EBIT

-3,8

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-952,1M

Profitability

Gross Margin

100%

EBITDA Margin

EBIT Margin

Net Margin

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

1,8%

% PPE

12,9%

% Goodwill

0%

ROE

ROIC

Growth

CAGR Revenue 5Y

-47,9%

CAGR Op. Income 5Y

-46,6%

CAGR Net Income 5Y

-68,2%

CAGR EPS 5Y

-73,9%

Leverage

N.D./EBITDA

0,9

Debt/Equity

0%

Current Ratio

3,2

Quick Ratio

2,5

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium